ARS Pharmaceuticals
SPRY
SPRY
72 hedge funds and large institutions have $200M invested in ARS Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
-2
Holders Change %
-2.7%
% of All Funds
1.11%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
19
Increased
27
Reduced
18
Closed
20
Calls
$406K
Puts
–
Net Calls
+$406K
Net Calls Change
+$542K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$9.26M |
| 2 |
2
Ensign Peak Advisors
Salt Lake City,
Utah
|
$2.73M |
| 3 |
3
BlackRock
New York
|
$10.5M |
| 4 |
WA
4
Wasatch Advisors
Salt Lake City,
Utah
|
$11.8M |
| 5 |
5
T. Rowe Price Associates
Baltimore,
Maryland
|
$2M |
